Results 11 to 20 of about 4,865,556 (281)

Effects of Audio‐Guided Imagery on Raynaud Phenomenon in Connective Tissue Disease [PDF]

ACR Open Rheumatology
Objective To assess the physical, emotional, and mental impact of regular audio‐guided imagery (AGI) in patients with connective tissue disease (CTD)–associated Raynaud phenomenon (RP).
Cristina Padilla, Veena Katikineni, Yongseok Park, Leigh Freno, Maureen Laffoon, Lee Reichbaum, Robert Lafyatis, Robyn Domsic   +7 more
doaj   +4 more sources

Primary Raynaud Disease

Journal of Osteopathic Medicine, 2019
Jay H Shubrook
exaly   +4 more sources

PLASMAPHERESIS IN RAYNAUD'S DISEASE [PDF]

Lancet, The, 1978
Understanding of the pathogenesis, clinical course, and treatment of Raynaud's disease is confused and unsatisfactory, and no success in treatment can be promised. Five patients with severe Raynaud's disease, who had not responded to other forms of treatment, were treated by plasmapheresis, which produced a striking improvement.
L T Cotton, L T Cotton
exaly   +10 more sources

Spurious Fingertip Oxygen Desaturation During the 6‐Minute Walk Test in a Patient With NSIP and Raynaud Phenomenon: The Value of Forehead Pulse Oximetry and Transcutaneous Oxygen Tension [PDF]

Respirology Case Reports
Reduced digital perfusion associated with Raynaud phenomenon may cause spuriously low fingertip pulse oximetry readings during the 6‐minute walk test (6MWT), potentially leading to overestimation of exercise‐induced hypoxaemia in patients with ...
Yusuke Nakamura, Masayoshi Takamori, Honoka Sunaga, Kosuke Natsume, Yuri Nomura, Yuto Goto, Nobuhiko Tsukada, Azusa Tsukada, Nobuhiko Uchida, Nana Yazawa, Hiromi Hoshi, Yasuo Shimizu, Seiji Niho   +12 more
doaj   +2 more sources

New-onset Raynaud phenomenon during ropeginterferon alfa-2b therapy for polycythemia vera: a case report and review of the literature [PDF]

Case Reports in Oncology
Introduction: Ropeginterferon alfa-2b is increasingly used as a disease-modifying cytoreductive therapy for polycythemia vera (PV), achieving durable hematologic control and molecular responses.
Migle Gasiene, Sara C. Meyer, Alicia Rovó   +2 more
doaj   +2 more sources

Toxin for Treating Raynaud Conditions in Hands (The TORCH Study): A Systematic Review and Meta-analysis

Plastic and Reconstructive Surgery, Global Open
Background:. Raynaud disease of the hands is a complex disorder resulting in inappropriate constriction and/or insufficient dilation in microcirculation.
Ellen Geary, MD, Justin C.R. Wormald, MRCS, PhD, Kevin J. Cronin, MSc, FRCS, Plast, Henk P. Giele, FRACS, MRACMA, Laura Durcan, MD, FRCPI, Oran Kennedy, PhD, Fergal O’Brien, PhD, Roisin T. Dolan, MD, FRCS, Plast   +7 more
doaj   +5 more sources

Primary Biliary Cholangitis with Associated Raynaud Syndrome Treatment Outcome: a Case Report [PDF]

Ķazaķstannyṇ Klinikalyķ Medicinasy
Primary biliary cholangitis is an autoimmune liver disease, which is less common than viral hepatitis and fatty liver disease, but in recent decades there has been a steady increase in the PBC occurrence.
Ainur Doszhan, Nina Tostanovskaya, Galiya Shaimardanova, Larissa Kozina, Gulsara Imambayeva, Assyltay Nauryzbayeva   +5 more
doaj   +3 more sources

Venodilation in Raynaud's disease

Lancet, The, 1993
The pathogenesis of Raynaud's disease is unclear; an enhanced response to catecholamines has been hypothesised to contribute to this vasospastic disorder. Impaired endothelium-dependent dilation occurs in other diseases associated with vasospasm, such as coronary atherosclerosis.
Terrence Blaschke, B B Hoffman
exaly   +3 more sources

A CASE OF RAYNAUD'S DISEASE. [PDF]

Lancet, The, 1890
n ...
Louise Stevenson
exaly   +3 more sources

Recent achievements in the management of Raynaud’s phenomenon

Vascular Health and Risk Management, 2010
Magnus Baumhäkel, Michael BöhmKlinik für Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinikum des Saarlandes, Homburg/Saar, GermanyAbstract: Raynaud’s ...
Magnus Baumhäkel, Michael Böhm   +1 more
doaj   +1 more source